Nergiz Döndü, Süren Dinç, Alikanoğlu Arsenal Sezgin, Yıldırım Hülya Tosun, Altun Zelal Akgündüz, Uslu Asım
Department of Pathology, University of Health Sciences, Antalya Training and Research Hospital, Kazım Karabekir Street, Muratpaşa, Antalya, 07050, Turkey.
Department of Plastic and Reconstructive Surgery, University of Health Sciences, Antalya Training and Research Hospital, Kazım Karabekir Street, Muratpaşa, Antalya, 07050, Turkey.
Aesthetic Plast Surg. 2022 Feb;46(1):83-90. doi: 10.1007/s00266-021-02558-z. Epub 2021 Sep 2.
Reduction mammoplasty (RM) is one of the most frequently performed surgical procedures. The incidental determination of significant pathologic lesions (SPL), that is precursor and malignant lesions, in RM specimens is rare. The aim of this study was to determine the frequency of SPL in RM specimens, to evaluate the relationship between SPL and clinicopathological factors, and to examine the incidence of invasive breast carcinoma forming in the remaining breast tissue during the postoperative follow-up period developing in patients after RM operation.
This retrospective study included 874 females who underwent RM operation between January 2012 and January 2021. Demographic, clinicopathological findings, and preoperative radiological findings were recorded. The patients were followed up after the RM operation in respect of the first occurrence of breast cancer.
Invasive carcinoma was determined in 0.2% and SPL in 3.5% in RM. The probability of SPL determination was greater in patients aged ≥ 40 years and with ≥ 4 paraffin blocks (p=0.038, p=0.01, respectively). No statistically significant difference was found between patients with and without SPL in respect of radiological findings (p=0.35). The mean postoperative follow-up period was 53.6 months, and invasive carcinoma was diagnosed during follow-up in 0.2% of all patients (6.9% of the patients with SPL).
Age over 40 years and an increased number of sampled blocks were found to be factors increasing the possibility of the determination of precursor and malignant lesions in RM specimens. RM could decrease the risk of the development of breast cancer.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
缩乳术(RM)是最常施行的外科手术之一。在RM标本中偶然发现重大病理病变(SPL),即癌前病变和恶性病变的情况较为罕见。本研究的目的是确定RM标本中SPL的发生率,评估SPL与临床病理因素之间的关系,并检查RM术后患者在术后随访期间剩余乳腺组织中发生浸润性乳腺癌的发生率。
这项回顾性研究纳入了2012年1月至2021年1月期间接受RM手术的874名女性。记录了人口统计学、临床病理结果和术前影像学检查结果。RM手术后对患者进行随访,观察乳腺癌的首次发生情况。
RM中浸润性癌的检出率为0.2%,SPL的检出率为3.5%。年龄≥40岁且石蜡块数≥4块的患者中发现SPL的可能性更大(分别为p = 0.038,p = 0.01)。在影像学检查结果方面,有SPL和无SPL的患者之间未发现统计学显著差异(p = 0.35)。术后平均随访期为53.6个月,所有患者中有0.2%在随访期间被诊断为浸润性癌(有SPL的患者中为6.9%)。
发现40岁以上年龄和增加采样块数是增加RM标本中癌前病变和恶性病变检出可能性的因素。RM可降低患乳腺癌的风险。
证据等级IV:本刊要求作者为每篇文章指定证据等级。有关这些循证医学评级的完整描述,请参阅目录或作者在线指南www.springer.com/00266 。